Premarket review refers to the process of evaluating data and information submitted in applications for various medical products before they can be marketed. This includes a thorough examination of submissions for new drugs, medical devices, and biologics to ensure they meet safety and effectiveness standards as defined by U.S. law.
Premarket review is primarily used in the fields of healthcare and pharmaceuticals. It is a critical step in the approval process for:
Users can manage some aspects of this process by utilizing legal templates available through platforms like US Legal Forms, which provide guidance on preparing necessary documentation.
Here are a couple of examples of abatement:
Example 1: A pharmaceutical company submits an NDA to the FDA for a new medication intended to treat high blood pressure. The FDA conducts a premarket review to assess the drug's safety and efficacy before granting approval.
Example 2: A manufacturer files a 510(k) application for a new medical device that claims to be substantially equivalent to an already approved device. The FDA reviews the submission to ensure it meets regulatory standards. (hypothetical example)
The primary statutes governing premarket review include:
| Term | Definition | Key Differences |
|---|---|---|
| Premarket Approval (PMA) | A rigorous process for high-risk medical devices. | PMA requires more extensive data than 510(k) submissions. |
| 510(k) Submission | A process for demonstrating that a device is safe and effective based on equivalence to a legally marketed device. | Less stringent than PMA; typically for lower-risk devices. |
If you are involved in the development of a medical product, ensure you understand the premarket review process. Here are steps to consider:
Browse our library of 85,000+ state-specific legal templates.
| Attribute | Details |
|---|---|
| Typical Fees | Varies based on submission type; PMA fees are generally higher. |
| Jurisdiction | Federal, overseen by the FDA. |
| Possible Penalties | Fines, product recalls, or legal action for non-compliance. |
Its purpose is to evaluate the safety and effectiveness of medical products before they can be marketed.